Ondenz
Ondenz (Ondansetron) 8mg/4ml by Nicholas Pharmaceuticals is I.M/ I.V injection, 1’s x 4ml ampoule. Ondenz provides prevention of nausea and vomiting associated with initial and repeat courses of emetogenic chemotherapy.
Package Contains: Each pack of Ondenz contains 4ml ampoule and a leaflet inserted inside.
Composition: 
Each 4ml ampoule contains:
Ondansetron (as hydrochloride) 8mg.
(Product complies USP specs.)
Dosage: See leaflet present inside for full prescribing information or use as directed by the physician.
Indications: Ondansetron is indicated for the prevention of nausea and vomiting associated with:
- Highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50mg/m2.
- Initial and repeat courses of moderately emetogenic cancer chemotherapy.
- Radiotherapy in patients receiving either total irridiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.
- Ondansetron is also indicated for the prevention of postoperative nausea and/or vomiting
Dosage & Administration: The recommended dosage for adult and pediatric patients 6 months of age and older for prevention of nausea and vomiting associated with emetogenic chemotherapy is 0.15mg/kg per dose for 3 doses (maximum of 16mg per dose) or as advised by the physician.
Caution: Do not use if ampoule is leaking, solution is turbid or contains foreign particles. Dilution of Ondenz (Ondansetron) Injection is réquired is adult and pediatric patients prior to administration. Infuse intravenously over 15 minutes beginning 30 minutes before the start of emetogenic chemotherapy and then repeat 4 and 8 hours after. Prevention of Postoperative Nausea and Vomiting: The recommended dose is the first dose.
Warning & Precautions
Hypersensitivity Reactions: If hypersensitivity reactions occur, discontinue use of Ondansetron; treat promptly as per standard of care and monitor until signs and symptoms resolve.
QT Prolongation: Avoid Ondansetron in patients with congenital long QT syndrome; ECG monitoring is recommended in patients with electrolyte abnormalities (e.g., hypokalemia or hypomagnesaemia), congestive heart failure, bradyarrhythmias, or patients taking other medicinal products that lead to QT prolongation.
Serotonin Syndrome: If symptoms of serotonin syndrome occur, discontinue Ondansetron and initiate supportive treatment. Patients should be informed of the increased risk of serotonin syndrome, especially if Ondansetron is used concomitantly with other serotonergic drugs.
Masking of progressive ileus and Gastric Distension: The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.
Warning: Do not use if ampoule is leaking, solution is turbid or contains foreign particles.
Instructions: 
- Store below 25℃ at dry place (Excursion permitted between 15℃ to 30℃.)
- Protect from heat and sunlight.
- Keep all medicine out of the reach of children.
- To be used and sold on the prescription of a registered medical practitioner only.
Manufacturer & Buy Online:
Ondenz medicine is manufactured by Palpex Pharmaceuticals (PVT) LTD.
This is the link to the manufacturer: https://palpex.com
The medicine is manufactured for Nicholas Pharmaceuticals.
This is the link to Nicholas Pharmaceuticals: https://nicholaspharma
The medicine is not currently available online, but you can buy it from any nearby pharmacy. It is currently (2026) available at the retail price of around 250 rupees.
By: Maliha Gul